Nemaura Medical Inc.
NMRD · OTC
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Market Cap | $22,266 | $102,187 | $170,245 | $121,925 |
| - Cash | $10,105 | $17,749 | $31,865 | $106 |
| + Debt | $20,030 | $19,189 | $24,922 | $0 |
| Enterprise Value | $32,191 | $103,627 | $163,302 | $121,819 |
| Revenue | $77 | $504 | $0 | $0 |
| % Growth | -84.7% | – | – | – |
| Gross Profit | -$1,476 | $160 | -$98 | $0 |
| % Margin | -1,916.3% | 31.7% | – | – |
| EBITDA | -$7,287 | -$7,341 | -$4,489 | -$4,724 |
| % Margin | -9,458.3% | -1,456.7% | – | – |
| Net Income | -$14,144 | -$13,887 | -$6,259 | -$4,160 |
| % Margin | -18,358% | -2,755.8% | – | – |
| EPS Diluted | -0.57 | -0.59 | -0.28 | -0.2 |
| % Growth | 3.4% | -110.7% | -40% | – |
| Operating Cash Flow | -$8,452 | -$6,504 | -$5,998 | -$3,450 |
| Capital Expenditures | -$539 | -$956 | -$836 | -$211 |
| Free Cash Flow | -$8,991 | -$7,461 | -$6,835 | -$3,661 |